Yoshinaga, T.; Yoshioka, Y.; Tsai, F.J.; Nelson, L.; Cheng, M.; Ito, R.; Fujita, S.; Ishikawa, E.; Kametani, F.; Aoyagi, R.;
et al. Clinical and Biochemical Characterization of Hereditary ATTR Amyloidosis Caused by a Novel Transthyretin Variant V121A (p.V141A). Int. J. Mol. Sci. 2025, 26, 4659.
https://doi.org/10.3390/ijms26104659
AMA Style
Yoshinaga T, Yoshioka Y, Tsai FJ, Nelson L, Cheng M, Ito R, Fujita S, Ishikawa E, Kametani F, Aoyagi R,
et al. Clinical and Biochemical Characterization of Hereditary ATTR Amyloidosis Caused by a Novel Transthyretin Variant V121A (p.V141A). International Journal of Molecular Sciences. 2025; 26(10):4659.
https://doi.org/10.3390/ijms26104659
Chicago/Turabian Style
Yoshinaga, Tsuneaki, Yuuki Yoshioka, Felix J. Tsai, Luke Nelson, Ming Cheng, Ryota Ito, Satoshi Fujita, Eri Ishikawa, Fuyuki Kametani, Ryuzi Aoyagi,
and et al. 2025. "Clinical and Biochemical Characterization of Hereditary ATTR Amyloidosis Caused by a Novel Transthyretin Variant V121A (p.V141A)" International Journal of Molecular Sciences 26, no. 10: 4659.
https://doi.org/10.3390/ijms26104659
APA Style
Yoshinaga, T., Yoshioka, Y., Tsai, F. J., Nelson, L., Cheng, M., Ito, R., Fujita, S., Ishikawa, E., Kametani, F., Aoyagi, R., Okumura, T., Murohara, T., Yazaki, M., & Sekijima, Y.
(2025). Clinical and Biochemical Characterization of Hereditary ATTR Amyloidosis Caused by a Novel Transthyretin Variant V121A (p.V141A). International Journal of Molecular Sciences, 26(10), 4659.
https://doi.org/10.3390/ijms26104659
